Physician profile
Punit Agrawal
NPI 1578787990
$35,815.93
in general payments reported to CMS, 2019-2025
71 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $6,710 · 2021: $7,561 · 2022: $4,098 · 2023: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $16,857.66 | 2019-2021 | |
| Biogen, INC. | $5,932.24 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $972.80 | 2019-2023 | Austedo Xr |
| Abbvie INC. | $595.12 | 2019-2023 | Botox, Duopa |
| Amgen INC. | $574.90 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $573.68 | 2019-2022 | |
| Ucb, INC. | $484.83 | 2019-2022 | |
| Emd Serono, INC. | $461.65 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $451.76 | 2019-2023 | Ongentys, Ingrezza |
| Amneal Pharmaceuticals LLC | $450.05 | 2019-2023 | Rytary |
| Lundbeck LLC | $426.03 | 2019-2023 | Vyepti |
| Eisai INC. | $408.05 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $373.45 | 2019-2023 | Nuplazid |
| Kyowa Kirin, INC. | $365.01 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $343.67 | 2019-2023 |
Show all 71 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Punit Agrawal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.